| Rotavirus disease and vaccination: impact on genotype diversity J Matthijnssens, J Bilcke, M Ciarlet, V Martella, K Bányai, M Rahman, ... Future microbiology 4 (10), 1303-1316, 2009 | 363 | 2009 |
| Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015) L Willem, F Verelst, J Bilcke, N Hens, P Beutels BMC infectious diseases 17, 1-16, 2017 | 192 | 2017 |
| Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide J Bilcke, P Beutels, M Brisson, M Jit Medical Decision Making 31 (4), 675-692, 2011 | 183 | 2011 |
| Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta … S Zhang, LZ Akmar, F Bailey, BA Rath, M Alchikh, B Schweiger, ... The Journal of infectious diseases 222 (Supplement_7), S680-S687, 2020 | 173 | 2020 |
| Biomass production efficiency controlled by management in temperate and boreal ecosystems M Campioli, S Vicca, S Luyssaert, J Bilcke, E Ceschia, FS Chapin III, ... Nature geoscience 8 (11), 843-846, 2015 | 157 | 2015 |
| Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ... Pharmacoeconomics 34, 227-244, 2016 | 127 | 2016 |
| The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe M Jit, J Bilcke, MJJ Mangen, H Salo, H Melliez, WJ Edmunds, Y Yazdan, ... Vaccine 27 (44), 6121-6128, 2009 | 115 | 2009 |
| Detection of human papillomavirus DNA in urine. A review of the literature A Vorsters, I Micalessi, J Bilcke, M Ieven, J Bogers, P Van Damme European journal of clinical microbiology & infectious diseases 31, 627-640, 2012 | 114 | 2012 |
| The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom AJ Van Hoek, A Melegaro, N Gay, J Bilcke, WJ Edmunds Vaccine 30 (6), 1225-1234, 2012 | 87 | 2012 |
| Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 … X Li, L Willem, M Antillon, J Bilcke, M Jit, P Beutels BMC medicine 18, 1-16, 2020 | 85 | 2020 |
| Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study J Bilcke, M Antillón, Z Pieters, E Kuylen, L Abboud, KM Neuzil, AJ Pollard, ... The Lancet Infectious Diseases 19 (7), 728-739, 2019 | 83 | 2019 |
| The health and economic burden of chickenpox and herpes zoster in Belgium J Bilcke, B OGUNJIMI, C Marais, F De Smet, M Callens, K Callaert, ... Epidemiology & Infection 140 (11), 2096-2109, 2012 | 73 | 2012 |
| Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver (s) and``No Medical Care''Disease Impact in Belgium J Bilcke, P Van Damme, P Beutels Medical Decision Making 29 (1), 33-50, 2009 | 73 | 2009 |
| Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all J Bilcke, S Coenen, P Beutels PloS one 9 (7), e102634, 2014 | 71 | 2014 |
| Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources J Bilcke, P Beutels Pharmacoeconomics 27, 281-297, 2009 | 70 | 2009 |
| Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014 M Sabbe, N Berger, A Blommaert, B Ogunjimi, T Grammens, M Callens, ... Eurosurveillance 21 (27), 30273, 2016 | 65 | 2016 |
| Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low-and middle-income settings M Antillón, J Bilcke, AD Paltiel, VE Pitzer Vaccine 35 (27), 3506-3514, 2017 | 64 | 2017 |
| Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis J Bilcke, P Van Damme, M Van Ranst, N Hens, M Aerts, P Beutels PloS one 4 (6), e6060, 2009 | 63 | 2009 |
| Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? J Bilcke, A Jan van Hoek, P Beutels Human vaccines & immunotherapeutics 9 (4), 812-822, 2013 | 57 | 2013 |
| Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium? VE Pitzer, J Bilcke, E Heylen, FW Crawford, M Callens, F De Smet, ... Scientific reports 5 (1), 18585, 2015 | 55 | 2015 |
